Jessica B. Johnson, MD, specializes in ulcerative colitis and Crohn’s disease. Her clinical interests and expertise are in inflammatory diseases of the intestinal tract that include inflammatory bowel disease (ulcerative colitis and Crohn’s disease) , transition in care from the pediatric to adult setting in patients with inflammatory bowel disease, treating inflammatory bowel disease in older patients, small bowel diseases, and women’s issues in gastroenterology.
Dr. Johnson received her MD degree from the University of South Florida College of Medicine in Tampa, Florida. She completed Internal Medicine Residency training at the University of Utah and spent an additional year as Chief Medical Resident. She then completed fellowship training in gastroenterology with subspecialty training in inflammatory bowel diseases at the University of Utah where she also served as Chief Fellow.
Dr. Johnson is board certified in Internal Medicine and Gastroenterology. She is a member of the American College of Gastroenterology, the American Gastroenterological Association, the American Society for Gastrointestinal Endoscopy, and the Crohn’s and Colitis Foundation of America.
Education History
| Fellowship |
University of Utah Hospitals and Clinics |
Fellow |
|---|---|---|
|
University of Utah Hospitals and Clinics |
Chief Medical Resident | |
| Residency |
University of Utah Hospitals and Clinics |
Resident |
|
University of South Florida Morsani College of Medicine |
MD | |
| Graduate Training |
University of South Florida Morsani College of Medicine |
MS |
|
Eckerd College |
BA |
Selected Publications
Journal Article
- Derek P, Jessica J, Brian S, Shoabo P, Wei C, Jorge R, Andrew G, Joshua B, Jeffrey C, Vicki S, David W, Jessica W (2020). P022 Utilization Patterns of Infliximab Originator to Infliximab Biosimilar in US Veterans. Am J Gastroenterol, 115(Suppl 1), S6. (Read full article)
- Johnson J, Affolter K, Boynton K, Chen X, Valentine J, Peterson K (2017). CMV Disease in IBD: Comparison of Diagnostic Tests and Correlation with Disease Outcome. Inflamm Bowel Dis, 24(7), 1539-1546. (Read full article)
- Johnson JB, Boynton KK, Peterson KA (2016). Co-occurrence of eosinophilic esophagitis and potential/probable celiac disease in an adult cohort: a possible association with implications for clinical practice. Dis Esophagus, 29(8), 977-982. (Read full article)
Case Report
- Johnson JB, Driscoll M, Cohen M, Adler DG (2016). Mycobacterium avium-Intracellulare Complex (MAC) Producing a Periportal Pseudotumor in a Patient With HIV and a Normal CD4 Count. ACG Case Rep J, 3(4), 92.
- Johnson JB, Affolter KE, Samadder NJ (2013). A rare cause of hematochezia: colon mucormycosis. Clin Gastroenterol Hepatol, 11(8), A22. (Read full article)
- Johnson JB, Marsden L, Samadder NJ (2013). A rare cause of diarrhea: pancreatic VIPoma. Endoscopy, 45 Suppl 2 UCTN, E311-2. (Read full article)
Abstract
- Johnson JB, Lynch K, Flynn A, et al (2014). CMV Disease in IBD: Comparison of Diagnostic Tests (Hematoxylin & Eosin, Immunohistochemistry, Tissue PCR) and Correlation with Disease Outcome; poster presentation also given at the Crohn’s & Colitis Foundation of America’s Clinical & Research Conference, Orlando, FL, December 2014 [Abstract]. Inflammatory Bowel Diseases Journal.